Management of metastatic head and neck squamous cell carcinoma is evolving as new
systemic therapies have led to improvements in survival, and as advances in locoregional …

There are several controversies in the management of head and neck cancer (SCCHN).
Although combined modality treatment is standard in locally advanced SCCHN (LA …

Background Recurrent/metastatic squamous cell carcinoma of head and neck (R/M SCCNH)
is still a difficult-to-treat disease with poor clinical outcomes and limited treatment choices. In …

We evaluated objective and subjective swallowing function outcomes in patients with
dysphagia treated for head and neck cancer (HNC) and identified risk factors for poor …

Tongue squamous cell carcinoma (TSCC) is the most common oral malignancy. The
proliferation status of tumor cells as indicated with Ki-67 index has great impact on tumor …

Importance Tumor histological factors that predict immunotherapy response in patients with
recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) are not well …

OBJECTIVE: The aim of this study was to identify features mainly involved in determining the
partial response (PR) to the Electrochemotherapy (ECT) in patients with recurrent and/or …

Background. Globally, head and neck squamous cell carcinoma (HNSCC) is a common
malignant tumor with high morbidity and mortality. Hence, it is important to find effective …

Systemic therapy remains a cornerstone in the multidisciplinary approach and management
of locally advanced squamous cell carcinoma of the head and neck (SCCHN) and the …

Purpose Mucositis remains a challenging complication of radiotherapy or
chemoradiotherapy (CRT) for head and neck cancer (HNC) patients. There is limited data on …